Advanced Search

ICD-10-PCS code List for Other Antineoplastic

ICD-10-PCS code List for Other Antineoplastic is medical classification list by Centers for Medicare and Medicaid Services (CMS).

PCS Tables

PCS CODE

Description

Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach

Introduction of Low-dose Interleukin-2 into Peripheral Artery, Open Approach

Introduction of Other Antineoplastic into Peripheral Artery, Open Approach

Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approach

Introduction of Clofarabine into Peripheral Artery, Open Approach

Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Open

Introduction of Other Thrombolytic into Peripheral Artery, Open Approach

Introduction of Oxazolidinones into Peripheral Artery, Open Approach

Introduction of Other Anti-infective into Peripheral Artery, Open Approach

Introduction of Anti-inflammatory into Peripheral Artery, Open Approach

Introduction of Serum, Toxoid and Vaccine into Peripheral Artery, Open Approach

Introduction of Nutritional Substance into Peripheral Artery, Open Approach

Introduction of Electrolytic and Water Balance Substance into Peripheral Artery, Open Approach

Introduction of Intracirculatory Anesthetic into Peripheral Artery, Open Approach

Introduction of Other Therapeutic Substance into Peripheral Artery, Open Approach

Introduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Open Approach

Introduction of Radioactive Substance into Peripheral Artery, Open Approach

Introduction of Other Diagnostic Substance into Peripheral Artery, Open Approach

Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Open Approach

Introduction of Platelet Inhibitor into Peripheral Artery, Open Approach

Introduction of Antiarrhythmic into Peripheral Artery, Open Approach

Introduction of Destructive Agent into Peripheral Artery, Open Approach

Introduction of Insulin into Peripheral Artery, Open Approach

Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Open Approach

Introduction of Other Hormone into Peripheral Artery, Open Approach

Introduction of Immunostimulator into Peripheral Artery, Open

Introduction of Immunosuppressive into Peripheral Artery, Open

Introduction of Vasopressor into Peripheral Artery, Open Approach

Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach

Introduction of Low-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach

Introduction of Other Antineoplastic into Peripheral Artery, Percutaneous Approach

Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach

Introduction of Clofarabine into Peripheral Artery, Percutaneous Approach

Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Percutaneous

Introduction of Other Thrombolytic into Peripheral Artery, Percutaneous Approach

Introduction of Oxazolidinones into Peripheral Artery, Percutaneous Approach

Introduction of Other Anti-infective into Peripheral Artery, Percutaneous Approach

Introduction of Anti-inflammatory into Peripheral Artery, Percutaneous Approach

Introduction of Serum, Toxoid and Vaccine into Peripheral Artery, Percutaneous Approach

Introduction of Nutritional Substance into Peripheral Artery, Percutaneous Approach

Introduction of Electrolytic and Water Balance Substance into Peripheral Artery, Percutaneous Approach

Introduction of Intracirculatory Anesthetic into Peripheral Artery, Percutaneous Approach

Introduction of Other Therapeutic Substance into Peripheral Artery, Percutaneous Approach

Introduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Percutaneous Approach

Introduction of Radioactive Substance into Peripheral Artery, Percutaneous Approach

Introduction of Other Diagnostic Substance into Peripheral Artery, Percutaneous Approach

Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Percutaneous Approach

Introduction of Platelet Inhibitor into Peripheral Artery, Percutaneous Approach

Introduction of Antiarrhythmic into Peripheral Artery, Percutaneous Approach

Introduction of Destructive Agent into Peripheral Artery, Percutaneous Approach

Introduction of Insulin into Peripheral Artery, Percutaneous Approach

Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Percutaneous Approach

Introduction of Other Hormone into Peripheral Artery, Percutaneous Approach

Introduction of Immunostimulator into Peripheral Artery, Percutaneous

Introduction of Immunosuppressive into Peripheral Artery, Percutaneous

Introduction of Vasopressor into Peripheral Artery, Percutaneous Approach